(Q57903847)
Statements
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group (English)
S Pignata
G Scambia
C Pisano
E Breda
S Greggi
A Febbraro
N Riva
V De Rosa
C Gallo
F Perrone
Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference